PACSIN2 and leukemia: PACSIN2 moreover may affect TPMT activity: indeed, the knock-down of PACSIN2 mRNA in human leukemia cells NALM6 resulted in significantly lower TPMT expression and enzymatic activity[70] that can in turn result in a higher tGTP availability and Rac-1 inhibition.